CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive income
Balance (in shares) at Mar. 31, 2024		61,415,105
Balance at Mar. 31, 2024	$ 374,508	$ 61	$ 1,070,874	$ (701,282)	$ 4,855
Increase (decrease) in Stockholders' Equity
Foreign currency translation adjustment	(432)				(432)
Unrealized loss on short-term investments	(99)				(99)
Exercise of stock options (in shares)		22,860
Exercise of stock options	66		66
Vesting of RSUs (in shares)		463,841
Vesting of RSUs	0
Stock-based compensation expense	9,475		9,475
Net loss	(53,772)			(53,772)
Issuance of prefunded warrants to purchase common stock, net of issuance costs	48,500		48,500
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs (in shares)		5,668,937
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs	48,204	$ 6	48,198
Exercise of pre-funded warrants (in shares)		739,225
Exercise of pre-funded warrants	1	$ 1
Balance (in shares) at Jun. 30, 2024		68,309,968
Balance at Jun. 30, 2024	426,451	$ 68	1,177,113	(755,054)	4,324
Balance (in shares) at Mar. 31, 2025		77,085,024
Balance at Mar. 31, 2025	415,843	$ 77	1,358,897	(948,579)	5,448
Increase (decrease) in Stockholders' Equity
Foreign currency translation adjustment	(938)				(938)
Unrealized loss on short-term investments	$ (269)				(269)
Exercise of stock options (in shares)	966	966
Exercise of stock options	$ 8		8
Vesting of RSUs (in shares)		721,184
Vesting of RSUs	2	$ 1	1
Stock-based compensation expense	8,762		8,762
Net loss	(86,693)			(86,693)
Balance (in shares) at Jun. 30, 2025		77,807,174
Balance at Jun. 30, 2025	$ 336,715	$ 78	$ 1,367,668	$ (1,035,272)	$ 4,241